Xun Li
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Automated full-process pipeline via multi-parametric MRI for tumor segmentation, molecular subtype classification and prognostic factor analysis in breast cancer.
Journal: Quantitative imaging in medicine and surgery
Published: November 20, 2025
Long non-coding RNA NORAD suppresses erastin-induced ferroptosis in breast cancer by upregulating SLC7A11 via targeting the FUS/NR3C1 axis: experimental studies.
Journal: International journal of surgery (London, England)
Published: October 30, 2024
Adjuvant chemotherapy for pT1-3N0-1 breast cancer patients with HR+, HER2- subtype: a propensity-score matched study with competing risk analysis.
Journal: Journal of cancer research and clinical oncology
Published: June 02, 2023
Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Journal: Cell cycle (Georgetown, Tex.)
Published: June 14, 2021
Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer.
Journal: Journal of clinical laboratory analysis
Published: November 19, 2019
High density lipoprotein coated calcium carbonate nanoparticle for chemotherapy of breast cancer.
Journal: Journal of biomaterials applications
Published: May 22, 2019
Katanin P80 expression correlates with lymph node metastasis and worse overall survival in patients with breast cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: September 19, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026